Grants per year
Personal profile
Research Interests
General Surgical Pathology and Urological Surgical Pathology
Diagnosis of genital urinary cancers including prostate, bladder, kidney, testis and other GU organs
Immunohistochemistry
Pathogenesis of prostate cancer, kidney cancer and bladder cancer
Identification of new molecular markers of GU cancers
Solid tumor banking for biological studies
Certifications and Licenses
Anatomic Pathology & Clinical Pathology |
Training Experience
1997 | Residency, University of Chicago Hospitals |
1998 | Fellowship, Johns Hopkins Hospital |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Molecular Pathology, PhD, University of California at San Diego
… → 1989
Molecular Pathology, PhD, University of California at San Diego
… → 1989
MD, Medicine, Beijing Medical University
… → 1982
Research interests keywords
- Bladder Cancer
- Kidney Cancer / Urinary Tract Cancer
- Pathology
- Prostate Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab versus Standard of Care in Men with High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study
Ross, A. E. (PD/PI) & Yang, X. J. (Co-Investigator)
Johns Hopkins University, Macrogenics, Inc.
4/1/24 → 7/4/28
Project: Research project
-
FOXAl regulates cytokine signaling and immune landscape in prostate cancer through ARIDlA
Zhang, B. (PD/PI) & Yang, X. J. (Co-Investigator)
Emory University, National Cancer Institute
8/1/23 → 7/31/28
Project: Research project
-
Therapeutic targeting of Aurora Kinase A in lethal prostate cancer using a novel inhibitor
Hussain, M. (PD/PI), Fenton, S. E. (Co-Investigator) & Yang, X. J. (Co-Investigator)
Emory University, U.S. Army Medical Research and Materiel Command
7/1/23 → 6/30/26
Project: Research project
-
Enhanced Targeting of CBP/p300 in a Subtype of Metastatic Prostate Cancer
Yu, J. (PD/PI), Yu, J. (PD/PI), Hussain, M. (Co-Investigator), Hussain, M. (Co-Investigator), Yang, X. J. (Co-Investigator), Yang, X. J. (Co-Investigator), Zhao, C. (Co-Investigator) & Zhao, C. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
4/1/22 → 3/31/25
Project: Research project
-
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)
Schaeffer, E. M. (PD/PI), Schaeffer, E. M. (PD/PI), Kundu, S. D. (Co-Investigator), Kundu, S. D. (Co-Investigator), Yang, X. J. (Co-Investigator) & Yang, X. J. (Co-Investigator)
Joan and Sanford I. Weill Medical College of Cornell University, National Cancer Institute
2/4/22 → 1/31/27
Project: Research project
-
Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical history
Smith, H., Jean, J., Duckett, D., Vormittag-Nocito, E., Nezami, B. G., Jennings, L. J., Ahrendsen, J. T., Yang, X. J., Primdahl, D., Conway, K., Zhong, W., Santana-Santos, L., Horbinski, C., Castellani, R. J., Sukhanova, M. & Jamshidi, P., Jan 1 2025, In: Journal of neuropathology and experimental neurology. 84, 1, p. 84-86 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
Mezzanotte-Sharpe, J., ONeill, A., Mayer, I. A., Arteaga, C. L., Yang, X. J., Wagner, L. I., Cella, D., Meropol, N. J., Alpaugh, R. K., Saphner, T. J., Swaney, R. E., Hoelzer, K. L., Gradishar, W. J., Abramson, V. G., Sundaram, P. K., Jilani, S. Z., Perez, E. A., Lin, N. U., Jahanzeb, M. & Wolff, A. C. & 2 others, , Sep 2024, In: Breast Cancer Research and Treatment. 207, 2, p. 275-282 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings
Gama, A., Xu, H., Yang, X. J. & Choy, B., Feb 2024, In: International Journal of Surgical Pathology. 32, 1, p. 11-16 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
Li, E. V., Lee, M. S., Guo, J., Dean, N., Kumar, S., Mi, X., Zhou, R., Neill, C., Yang, X., Ross, A. E. & Krambeck, A. E., Dec 2024, In: Prostate. 84, 16, p. 1427-1433 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Molecular Pathogenesis of Renal Neoplasms in Patients with Birt–Hogg–Dubé Syndrome
Nezami, B. G., Teh, B. T., Lin, X. & Yang, X. J., Dec 2024, In: Journal of Molecular Pathology. 5, 4, p. 478-496 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access
Datasets
-
Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation
Yang, X. J. (Contributor), Tan, M.-H. (Contributor), Kim, H. L. (Contributor), Ditlev, J. A. (Contributor), Betten, M. W. (Contributor), Png, C. E. (Contributor), Kort, E. J. (Contributor), Futami, K. (Contributor), Furge, K. A. (Contributor), Takahashi, M. (Contributor), Kanayama, H.-O. (Contributor), Tan, P. H. (Contributor), Teh, B. S. (Contributor), Luan, C. (Contributor), Wang, K. (Contributor), Pins, M. (Contributor), Tretiakova, M. (Contributor), Anema, J. (Contributor), Kahnoski, R. (Contributor), Nicol, T. (Contributor), Stadler, W. (Contributor), Vogelzang, N. G. (Contributor), Amato, R. (Contributor), Seligson, D. (Contributor), Figlin, R. (Contributor), Belldegrun, A. (Contributor), Rogers, C. G. (Contributor) & Teh, B. T. (Contributor), ArrayExpress, 2007
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-2748
Dataset